Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices 104159 

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

PHEP Recipients ............................................ Capability 9—Medical Materiel Management 

and Distribution.

62 1 195/60 

PHEP Recipients ............................................ Capability 10—Medical Surge ........................ 62 1 2 

PHEP Recipients ............................................ Capability 11—Nonpharmaceutical Intervention.62 1 1.5 

PHEP Recipients ............................................ Capability 12—Public Health Laboratory 

Testing.

62 1 1.5 

PHEP Recipients ............................................ Capability 13—Public Health Surveillance 

and Epidemiological Investigation.

62 1 2.5 

PHEP Recipients ............................................ Capability 14—Responder Safety and Health 62 1 1.5 

PHEP Recipients ............................................ Capability 15—Volunteer Management ......... 62 1 75/60 

PHEP Recipients ............................................ Multiyear training and exercise plans 

(MYTEP)—training and exercise planning 

workshop.

62 1 1 

PHEP Recipients ............................................ MYTEP—training and exercise planning (annual).62 1 2 

PHEP Recipients ............................................ Capability 13—Quality improvement process 62 1 20/60 

PHEP Recipients ............................................ PHEP functional exercise (FE), full-scale exercise (FSE) or incident—annual PHEP 

exercise.

62 1 20/60 

PHEP Recipients ............................................ PHEP FE, FSE, or incident—annual staff notification and assembly performance measure.62 1 1.5 

Directly Funded Localities ............................... Facility setup drill ........................................... 4 1 45/60 

Directly Funded Localities ............................... Site activation drill .......................................... 4 1 1 

PHEP Recipients ............................................ EOC activation ............................................... 62 2 30/60 

PHEP Recipients ............................................ PHEP FE, FSE, or incident—Five-year joint 

exercise.

62 1 20/60 

PHEP Recipients ............................................ Five-year Distribution FSE OR Five-year 

Pan-flu FSE.

62 1 0.5 

Five-year Dispensing FSE ............................. * 4 1 0.5 

PHEP Recipients ............................................ Five-year pan flu functional exercise ............. 62 1 45/60 

PHEP Recipients ............................................ Tabletop exercise (TTX)—Administrative or 

fiscal preparedness.

62 1 20/60 

PHEP Recipients ............................................ TTX—Continuity of Operations ...................... 62 1 20/60 

Directly Funded Localities and Freely Associated States.Dispensing Throughput Drill ........................... 12 1 20/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–30483 Filed 12–19–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–25–24IV] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled 

‘‘Comprehensive Evaluation of the 

Implementation and Uptake of the CDC 

Clinical Practice Guideline for 

Prescribing Opioids for Pain’’ to the 

Office of Management and Budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on October 1, 2024, to obtain 

comments from the public and affected 

agencies. There were two public 

comments related to the previous 

notice. This notice serves to allow an 

additional 30 days for public and 

affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 


ddrumheller on DSK120RN23PROD with NOTICES1
104160 Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Comprehensive Evaluation of the 

Implementation and Uptake of the CDC 

Clinical Practice Guideline for 

Prescribing Opioids for Pain—New— 

National Center for Injury Prevention 

and Control (NCIPC), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Beginning in the 1990s, opioid 

prescribing rates for pain management 

steadily increased until 2010, remained 

steady until 2012, and have declined 

since then. The increase in opioid 

prescribing rates corresponded with 

increases in opioid-involved overdose 

deaths, which initially primarily 

involved prescription opioids (natural 

and semi-synthetic opioids and 

methadone). In response to this 

emerging crisis, CDC issued the CDC 

Guideline for Prescribing Opioids for 

Chronic Pain—United States, 2016 

(2016 CDC Guideline). Implementing 

the 2016 CDC Guideline was associated 

with reductions in opioid prescribing 

and increases in use of non-opioid 

medications for pain. At the same time, 

laws and policies related to prescribing 

opioids were instituted that misapplied 

or were inconsistent with the 2016 CDC 

Guideline, potentially contributing to 

patient harm. In 2022, CDC released the 

CDC Clinical Practice Guideline for 

Prescribing Opioids for Pain—United 

States, 2022, (2022 CDC Clinical 

Practice Guideline) which provided up 

to date evidence regarding pain 

management approaches and reemphasizes the need for prescribers to 

be focused on patient-centered care to 

provide effective pain management. 

CDC is comprehensively evaluating the 

uptake, implementation, and outcomes 

of the 2022 CDC Clinical Practice 

Guideline on evidence-based care for 

pain management to understand its 

impact. 

To meet CDC’s goal for a rigorous, 

comprehensive evaluation, this 

collection is proposing a mixed-method 

quasi-experimental approach to evaluate 

the 2022 CDC Clinical Practice 

Guideline. The evaluation includes 

dissemination and impact of the 2022 

CDC Clinical Practice Guideline through 

population-wide changes in prescribing 

practices for opioids and medications 

for opioid use disorder. Also, evaluation 

of the implementation of the 2022 CDC 

Clinical Practice Guideline comes from 

perspectives of patients, caregivers, 

clinicians; and leaders from health 

systems, payers, professional 

associations, and medical boards. 

CDC will use this information 

collection to evaluate the dissemination, 

impact, and implementation of the 2022 

CDC Clinical Practice Guideline to 

ensure that Americans have access to 

safer, effective ways of managing their 

pain. CDC requests OMB approval for an 

estimated 310 annual burden hours. 

There are no costs to respondents other 

than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Clinicians ......................................................... Clinician Survey .............................................

Invitation .........................................................

200 

1000 

1 

1 

10/60 

5/60 

Follow up Emails ............................................ 1000 1 5/60 

Clinician Interview .......................................... 10 1 1 

Dentists ........................................................... Dentist Interview ............................................. 2 1 1 

Health System Leaders .................................. Health System Leaders Interview .................. 3 2 1 

Payers ............................................................. Payer Interview .............................................. 3 2 1 

Professional Association Leaders ................... Professional Association Leaders Interview .. 3 2 1 

Medical Board Leaders ................................... Medical Board Leaders Interview .................. 3 2 1 

Patients ........................................................... Patient Focus Groups .................................... 15 3 1 

Caregivers ....................................................... Caregiver Focus Groups ................................ 15 2 1 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–30482 Filed 12–19–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–25–0234] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘National 

Ambulatory Medical Care Survey 

(NAMCS)’’ to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on 

September 20, 2024 to obtain comments 

from the public and affected agencies. 

CDC did not receive comments related 

to the previous notice. This notice 

serves to allow an additional 30 days for 

public and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 


ddrumheller on DSK120RN23PROD with NOTICES1